Callodine Capital Management’s Bain Capital Specialty BCSF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.5M Buy
200,000
+92,651
+86% +$1.21M 0.16% 47
2026
Q1
$1.33M Hold
107,349
0.09% 53
2025
Q4
$1.49M Buy
+107,349
New +$1.5M 0.12% 49
2024
Q4
Sell
-75,826
Closed -$1.26M 44
2024
Q3
$1.26M Buy
+75,826
New +$1.26M 0.26% 41
2023
Q3
Sell
-42,800
Closed -$578K 43
2023
Q2
$578K Buy
+42,800
New +$529K 0.17% 35
2021
Q4
Sell
-199,846
Closed -$2.97M 42
2021
Q3
$2.97M Buy
199,846
+89,846
+82% +$1.37M 1.12% 34
2021
Q2
$1.68M Sell
110,000
-75,000
-41% -$1.18M 0.64% 35
2021
Q1
$2.73M Buy
185,000
+10,000
+6% +$138K 1.19% 30
2020
Q4
$2.12M Buy
175,000
+85,000
+94% +$942K 1.03% 27
2020
Q3
$918K Buy
+90,000
New +$940K 0.49% 33

Other funds holding BCSF

Callodine Capital Management's BCSF Position: Q2 2026 in Review

Callodine Capital Management increased its Bain Capital Specialty (BCSF) stake by 86% in Q2 2026, buying an estimated $1.21M and bringing the position to 200,000 shares worth $2.5M. The position accounts for 0.16% of the portfolio, ranked #47.

Callodine Capital Management first reported a position in BCSF in Q3 2020 and has held it in 10 quarters since. The position peaked at $2.97M in Q3 2021. 128 funds tracked by Wall St. Rank hold BCSF as of Q2 2026.

  • Callodine Capital Management held 200,000 shares of Bain Capital Specialty worth $2.5M as of Q2 2026.
  • Callodine Capital Management bought 92,651 Bain Capital Specialty shares in Q2 2026, an estimated $1.21M.
  • Bain Capital Specialty made up 0.16% of Callodine Capital Management's portfolio in Q2 2026, its #47 holding.
  • Callodine Capital Management first reported a position in Bain Capital Specialty in Q3 2020 and has held it in 10 quarters since.
  • Callodine Capital Management's Bain Capital Specialty position peaked at $2.97M in Q3 2021.
  • 128 funds tracked by Wall St. Rank held Bain Capital Specialty as of Q2 2026.

Based on Callodine Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.